Drugs / HYDROTALCITE ANHYDROUS
HYDROTALCITE ANHYDROUS
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT03635372 | Jun → Oct 2017 | dyspepsia | Pamukkale University | Completed | No outcome recorded |
| Phase 4 | NCT01928888 | May 2003 → Feb 2004 | dyspepsia | Bayer | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05808010 | Jun 2023 → Apr 2025 | chronic atrophic gastritis | Shandong Provincial Hospital | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT05249725 Comparator | Apr → Aug 2022 | gastrointestinal mucositis | Lee's Pharmaceutical Limited | Unknown | No outcome recorded |
| — | NCT02955134 Background | Mar 2018 → May 2021 | chronic atrophic gastritis | Wangjing Hospital, China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2026-09-23 | Bayer | Bayer launches mono-material PP blister for Talcid® in Germany bayer.com ↗ |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HYDROTALCITE ANHYDROUS | ChEMBL registry synonym — accepted as the source's own label CHEMBL3833409 ↗ |
| Known as | BAY4516H | “Talcid (Hydrotalcite, BAY4516H)” NCT01928888 ↗ |
| Known as | Hi-ti | ChEMBL registry synonym — accepted as the source's own label CHEMBL3833409 ↗ |
| Known as | Hidrotalcita | ChEMBL registry synonym — accepted as the source's own label CHEMBL3833409 ↗ |
| Known as | Hydrotalcite | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03635372 ↗ |
| Known as | Nacid | ChEMBL registry synonym — accepted as the source's own label CHEMBL3833409 ↗ |
| Known as | Talcid | “Talcid (Hydrotalcite, BAY4516H)” NCT01928888 ↗ |
| Modality | Small molecule | — CHEMBL3833409 ↗ |
| Route | Oral | “single oral administration of 1000 mg Talcid®” NCT01928888 ↗ |